CTOs on the Move

Neuwave

www.neuwave.com

 
NeuWave Medical specializes in developing and commercializing energy-based minimally invasive medical devices. These devices must deliver improved healthcare economics and a better experience for patients in terms of outcomes or quality of life. NeuWave Medical, Inc. is a spin-off company from the University of Wisconsin - Madison. NeuWave arose as the result of an academic collaboration between engineers and physicians who wished to improve their ability to treat cancer and other important clinical problems. As a result, NeuWave is highly focused on solving real clinical problems in a manner that will directly benefit patients by being more effective, minimally ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.neuwave.com
  • 3529 Anderson St
    Madison, WI USA 53704
  • Phone: 608.512.1500

Executives

Name Title Contact Details

Funding

Neuwave raised $25M on 05/22/2015

Similar Companies

Jewish Home Of Rochester

Jewish Home Of Rochester is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Orthopaedic Innovations Inc

Orthopaedic Innovations Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neuralstem

Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic

Sybron Dental Specialties, Inc.

Sybron Dental Specialties, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Anaheim, CA. To find more information about Sybron Dental Specialties, Inc., please visit www.sybrondental.com

Grove Hill Memorial Hospital Inc

Grove Hill Memorial Hospital Inc is a Grove Hill, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.